Pay in 4 interest-free payments of $6.52 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Omada members, on average, experienced virtually no weight gain 16 weeks after discontinuing a GLP-1 compared to an average of 6% to 7% weight gain estimated from trial data, according to the company's analysis
Research-use-only designation requires verification that buyers represent legitimate research institutionsit does not permit personal use or bodybuilding applications
The phase 2 trial is expected to start in the second half of 2024, providing more data on its effectiveness and safety
Journal of Translational Autoimmunity
Defy Medical Defy Medical earns a 4.6/5.0 on our weighted scoring system
M.KhatibM.SimkhadaP.GodeD.et al (2014)
US$ 27.46
US$ 22.96
US$ 27.77
US$ 27.57
US$ 21.29
US$ 28.72
US$ 21.31
US$ 29.68
